Cardinal Health, Inc. (CAH)

NYSE - NYSE Real Time Price. Currency in USD
79.42-0.30 (-0.38%)
As of 1:18 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close79.72
Bid79.32 x 200
Ask79.34 x 300
Day's Range79.11 - 79.99
52wk Range73.25 - 91.23
1y Target EstN/A
Market Cap25.3B
P/E Ratio (ttm)18.38
Avg Vol (3m)2,172,789
Dividend & Yield1.80 (2.25%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals3 hours ago

    Cardinal Health acquisition a big win for Midwestern startup community

    Cardinal Health Inc.'s acquisition of a telemedicine software maker has a growing startup community celebrating its big exit – in Iowa. Dublin-based Cardinal (CAH) confirmed to Columbus Business First that it has acquired TelePharm LLC of Iowa City for an undisclosed sum. An investor called it an "eight-figure investment" by Cardinal, or north of $10 million, in a story in the Corridor Business Journal, a publication covering the Iowa City and Cedar Rapids region.

  • PR Newswire4 hours ago

    Fighting Prescription Drug Misuse through Community Programs: Cardinal Health Foundation Announces Generation Rx Medication Disposal Grants

    DUBLIN, Ohio, Aug. 31, 2016 /PRNewswire/ -- Non-profit organizations across the country were awarded grants from the Cardinal Health Foundation to help fight prescription drug misuse by improving their ...

  • American City Business Journals21 hours ago

    Rev1 Ventures lands big corporate support in launching $22M fund

    Rev1 Ventures is launching a $22 million fund to invest in early-stage and growing startups with the first significant participation from Central Ohio corporations. “It’s really broadened the base of support for startups in our region and gotten the corporate base involved,” Rev1 CEO Tom Walker said. The fund was seeded with an $8 million Ohio Third Frontier loan , and the nonprofit investment and advising group for technology startups raised $14 million in matching investments, including investing Rev1's own returns from previous funds.